| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |